Issue 7, 2013

Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections

Abstract

Alanine scanning has been used to define the key residues for the activity of RNA III inhibiting peptide (RIP) against S. aureus. We have found that the threonine residue at position 5 is detrimental to the RIP activity, while the removal of serine (P2) and phenylalanine (P7) afforded the most active RIP derivatives (2 and 7). Moreover, we have identified the small RIP derivative (9), corresponding to the sequence H-Ser-Pro-Trp-Thr-NH2, which displayed the best antistaphylococcal activity.

Graphical abstract: Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections

Article information

Article type
Concise Article
Submitted
23 Apr 2013
Accepted
15 May 2013
First published
15 May 2013

Med. Chem. Commun., 2013,4, 1114-1117

Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections

L. Baldassarre, E. Fornasari, C. Cornacchia, O. Cirioni, C. Silvestri, P. Castelli, A. Giocometti and I. Cacciatore, Med. Chem. Commun., 2013, 4, 1114 DOI: 10.1039/C3MD00122A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements